An observational study assessing effectiveness and safety in clinical practice of Ustekinumab in Ulcerative-colitis in the medium and long-term
Latest Information Update: 29 Nov 2022
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
Most Recent Events
- 29 Nov 2022 New trial record
- 11 Oct 2022 Results presented at the 30th United European Gastroenterology Week